Hikma Pharmaceuticals Plc Director/PDMR Shareholding (3967S)
December 20 2016 - 10:24AM
UK Regulatory
TIDMHIK
RNS Number : 3967S
Hikma Pharmaceuticals Plc
20 December 2016
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
The attached individual notification made under article 19.1 of
the Market Abuse Regulation ("MAR") relates to the transfer of
Ordinary Shares in Darhold Limited (which owns 25.00% of the
Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC
("Hikma")) from Mazen Darwazah to The TWMR Trust, a trust for the
benefit of Mazen Darwazah and his family. This announcement is made
in accordance with article 19.3 of MAR.
1 Details of the person discharging managerial
responsibilities / person closely associated
--- --------------------------------------------------------------
a) Name Mazen Darwazah
--- --------------------- ---------------------------------------
2 Reason for the notification
--- --------------------------------------------------------------
a) Position/status Executive Vice Chairman / PDMR
--- --------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ---------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- --------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC ('Hikma')
--- --------------------- ---------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ---------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- --------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ---------------------------------------
b) Nature of Transfer of 5,449,716 Ordinary Shares
the transaction of Darhold Limited (who holds 25.00%
of the issues share capital of Hikma)
to The TWMR Trust, a trust for the
benefit of Mazen Darwazah and members
of his immediate family.
--- --------------------- ---------------------------------------
c) Price(s) and Price(s): GBP0.00
volume(s) Volume(s): 0
--- --------------------- ---------------------------------------
d) Aggregated Aggregated volume: 0
information Price: GBP0.00
--- --------------------- ---------------------------------------
e) Date of the 20 December 2016
transaction
--- --------------------- ---------------------------------------
f) Place of the Jersey
transaction
--- --------------------- ---------------------------------------
Peter Speirs, Company Secretary, Responsible for releasing this
announcement
20 December 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBUBDDXDDBGLG
(END) Dow Jones Newswires
December 20, 2016 10:24 ET (15:24 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024